Legal & General Cuts Its Venture Capital Team

Legal & General has cut its venture capital team, Citywire reported, making the 190-year-old UK insurer the latest large financial group to pull back from corporate venturing.

Citywire described the move as an exclusive disclosure. The report did not specify how many roles the cuts affect, when they take effect, or which portfolio commitments the decision covers. Legal & General had not publicly detailed the restructuring before the Citywire story ran.

The decision matters because it removes one of the more visible corporate venture balance sheets from the UK and European startup ecosystem. Legal & General, one of Britain's largest asset managers and insurers, had used its venturing activity to place insurer capital directly into early-stage companies, alongside its much larger allocations to private markets, infrastructure and pension risk transfer deals.

What does the cut signal about corporate venturing?

Corporate venture arms have contracted across the board since interest rates turned sharply higher in 2022 and 2023. Financial institutions that launched or expanded VC units during the cheap-money era have faced pressure from three directions:

• Higher funding costs, which depress the valuations of the private startup stakes these teams hold;
• Shareholder demands for capital discipline, particularly at insurers balancing Solvency-style capital charges against illiquid early-stage exposure;
• Weak exit markets, which make it harder to convert portfolio marks into realized returns.

Against that backdrop, a decision by a balance-sheet-backed investor like Legal & General to cut its venture team reads as a capital-allocation call rather than a signal about any single portfolio company. Insurers can earn more predictably from credit, infrastructure and annuity business than from early-stage equity in the current environment.

Where does this leave L&G's innovation strategy?

Legal & General has positioned itself in recent years around retirement solutions, pension risk transfer and real assets, including large infrastructure and housing commitments through its investment management arm. A retreat from direct venture investing does not necessarily mean an exit from innovation spending altogether — large insurers often shift from equity stakes to procurement, partnerships or fund-of-funds exposure when they disband internal VC teams.

Citywire's report did not state whether Legal & General will maintain existing portfolio positions through maturity, wind them down, or transfer them to another part of the investment business. That question will define the practical impact on the startups that counted the insurer among their backers.

Who is affected?

The Citywire report named the venture team cuts but did not disclose the identities of the team members departing, the size of the fund or funds they managed, or the timing of the redundancies. Legal & General has been contacted for comment by trade press following the report, according to the Citywire coverage pattern typical of such exclusives.

For founders and co-investors, the loss of a corporate backer mid-cycle usually triggers a review of information rights, board observer seats and follow-on obligations. Portfolio companies will be watching for Legal & General's formal statement on how existing commitments will be honored.

What comes next?

The move will fuel debate over whether corporate venturing at European insurers can survive the current rate environment or whether it will remain a feature of low-rate cycles only. Legal & General's next public disclosures — including any statement on portfolio run-off and on where innovation spending lands within the group — will show whether this is a full strategic retreat or a narrower restructuring of one team.